اصلاح مقاله
یک ماه پیش منتشر شده
تعداد بازدید: 73
کد پروژه: 576066
شرح پروژه
سلام
سلام وقتتون بخیر
جسارتا یک مقاله در حوزه علوم شناختی برای یک ژورنال فرستادم و ایمیل اصلاحیه خورده متأسفانه وقت ویرایش ندارم
ویرایش هم از لحاظ علمی نیاز داره و هم از لحاظ گرامر .
هزینه انجام ویرایش رو لطف کنید بفرمایید
اینم کامنت اصلاحات
this work provides timely, methodologically sound evidence supporting tDCS as a promising non-pharmacological intervention for memory deficits in MCI. Revisions should more thoroughly contextualize the exclusion of tACS/tRNS, strengthen quantitative synthesis of effect sizes with confidence intervals, and resolve ambiguities in risk-of-bias assessments. With these refinements, the manuscript will offer valuable guidance for clinical practice and future research in cognitive neuromodulation.
Minor revisions:
. Introduction
• Contrast tDCS more sharply with pharmacotherapy (e.g., cost, side-effect profile).
• Simplify neurophysiological jargon (e.g., "theta-gamma phase-amplitude synchronization").
• Explicitly state how this review overcomes Manenti et al. (2024) uncertainties.
. Methods
o Resolve ambiguity in Table 3: Why is "Same outcome measurement" scored "N" for Yin Chen 2024?
o Define "independent demographic information" (e.g., comorbidities, APOE status).
. Results
• Table 1:
o Standardize "Diagnosis instruments" (e.g., note if MoCA/MMSE cutoffs varied).
o Report dropout rates.
• Table 2:
o Specify "sham" protocols (e.g., "30-sec ramp-up/down").
o Clarify "Co-intervention": Distinguish concurrent vs. sequential training.
• Subgroup Analyses:
o Report effect sizes with 95% CIs for all outcomes (e.g., RAVLT recognition).
o Quantify heterogeneity (I² statistics) where possible.
. Discussion
• Clinical Implications:
o Emphasize cost-effectiveness (e.g., "70% reduction with home-based tDCS" from Park 2024).
o Discuss feasibility of ≥10 sessions in elderly populations.
• Limitations:
o Address diagnostic variability (DSM-5 vs. ICD; 40% non-standardized).
o Acknowledge potential performance bias from sensory side effects (20–30% unblinding).
• Recommendations:
o Prioritize "biomarker-guided personalization" (e.g., fMRI/EEG pre-screening).
Tables & Figures
• Figure 1 (PRISMA): Update to reflect final included studies (n=10).
• Table 3 (Risk of Bias):
o Include a footnote defining "U" (unclear) vs. "N/A."
o Resolve discrepancies (e.g., "Blinding assessors" marked "N" for Lau 2024 but JBI score=11/13).
• Supplement: Consider adding forest plots for key outcomes.
Language & Clarity
• Tense: Use past tense for methods/results (e.g., "we extracted" not "we extract").
• Jargon: Define acronyms at first use (e.g., CRIq in Results).
• Flow: Improve transition between sections (e.g., link subgroup results to clinical recommendations).
این پروژه شامل 2 فایل مهم است، لطفا قبل از ارسال پیشنهاد حتما نسبت به بررسی این فایل اقدام فرمایید.
مهارت ها و تخصص های مورد نیاز
مبلغ پروژه
300,000 تومان
مهلت برای انجام
5روز
وضعیت مناقصه
انجام شده
درباره کارفرما
عضویت دو سال پیش
